LifeSplice Pharma
Gordon Lutz is the CEO of LifeSplice Pharma, a company that develops specific RNA-based drugs for diseases with unmet medical needs. Prior to their current role, Gordon worked as an Associate Professor at Drexel University College of Medicine. Gordon obtained their PhD in Biology from the University of Pennsylvania.
This person is not in any offices
LifeSplice Pharma
LifeSplice Pharma is an early-stage biotech company that develops extraordinarily specific, potent, and long-lasting RNA-based drugs called 'Splice Modulating Oligomers' (SMOs) to treat severe neurological and non-neurological diseases with critical unmet medical needs.